Gangliosides protect human melanoma cells from ionizing radiation-induced clonogenic cell death

Glycoconjugate Journal

Volumn 13, Issue 3, 1996, Pages 377-384

  Thomas, C P ^a   Buronfosse, A ^a   Combaret, V ^a   Pedron, S ^a   Fertil, B ^b   Portoukalian, J ^a  

^a CENTRE LÉON BÉRARD   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

gangliosides; human melanoma clones; radiosensitivity in vitro; sialic acid; spontaneous metastatic potential in vivo

Indexed keywords

GANGLIOSIDE;

ARTICLE; CELL DEATH; HUMAN; HUMAN CELL; IONIZING RADIATION; LUNG METASTASIS; MELANOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PROTECTION; RADIOSENSITIVITY;

ANIMALS; ANTIBODIES, MONOCLONAL; CATTLE; CELL DEATH; CELL SURVIVAL; CLONE CELLS; COBALT RADIOISOTOPES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FLOW CYTOMETRY; FUMONISINS; G(M1) GANGLIOSIDE; GAMMA RAYS; GANGLIOSIDES; HUMANS; LUNG NEOPLASMS; MELANOMA; MYCOTOXINS; NEURAMINIDASE; PARTICLE ACCELERATORS; RADIATION, IONIZING; RADIATION-PROTECTIVE AGENTS; RATS; RATS, WISTAR; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; VIBRIO CHOLERAE;

BOVINAE; VIBRIO CHOLERAE;

EID: 0029972889     PISSN: 02820080     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00731470     Document Type: Article

References (28)

1. Grdina DJ, Basic I, Mason KA, Withers HR (1975) Rad Res 63: 483-93.
2. Hill HZ, Hill GJ, Miller CF, Kwong F, Purdy J (1979) Rad Res 80: 259-76.
3. Leith JT, Dexter DL, Dewyngaert JK, Zeman EM, Chu MY, Calabresi P, Glicksman AS (1982) Cancer Res 42: 2556-61.
4. Welch DR, Milas L, Tomasovic SP, Nicolson GL (1983) Cancer Res 43: 6-10.
5. Yang X, Darling JL, McMillan TJ, Peacock JH, Steel GG (1991) Int J Rad Oncol Biol Physics 22: 103-8.
6. Buronfosse A, Thomas CP, Ginestet C, Doré JF (1994) C R Acad Sci Paris 317: 1031-41.
7. Fidler IJ (1973) Nature 242: 148-49.
8. Bailly M, Doré JF (1991) Int J Cancer 49: 750-57.
9. Suit H, Allam A, Allalunis-Turner J, Brock W, Girinsky T, Hill S, Hunter N, Milas L, Pearcey R, Peters L, Welch DR, West C, Efird J (1994) Cancer Res 54: 1736-41.
10. Thomas CP, Buronfosse A, Portoukalian J, Fertil B (1995) Cancer Lett 88: 221-25.
11. Ramakrishnan N, McClain DE, Catravas GN (1993) Int J Rad Biol 63: 693-701.
12. Kono K, Tsuchida T, Kern DH, Irie R (1990) Cancer Invest 8: 161-67.
13. Haimovitz-Freidman A, Kan CC, Ehleiter D, Persaud RS, McIloughlin M, Fuks Z, Kolesnick RN (1994) J Exp Med 180: 525-35.
14. Zebda N, Pedron S, Rebbaa A, Portoukalian J, Berthier-Vergnes O (1995) FEBS Lett 362: 161-64.
15. Bailly M, Bertrand S, Doré JF (1991) Int J Cancer 49: 457-66.
16. Portoukalian J, Carrel S, Doré JF, Rümke P (1991) Int J Cancer 49: 893-99.
17. Portoukalian J, Bouchon B (1986) J Chromatogr 380: 386-92.
18. Bouchon B, Portoukalian J, Madec AM, Orgiazzi J (1990) Biochim Biophys Acta 1051: 1-5.
19. Jourdian GW, Dean L, Roseman S (1971) J Biol Chem 246: 430-35.
20. Bailly M, Bertrand S, Doré JF (1993) Melanoma Res 3: 51-61.
21. Fertil B, Dertinger H, Courdi A, Malaise EP (1984) Rad Res 99: 73-84.
22. Harel R, Futerman AH (1993) J Biol Chem 268: 14476-81.
23. Manev H, Favaron M, Vicini S, Guidotti A, Costa E (1990) J Pharmcol Exp Ther 252: 419-27.
24. Koike T, Fehsel K, Zielasek J, Kolb H, Burkart V (1993) Immunol Lett 35: 207-12.
25. Ferrari G, Anderson BL, Stephens RM, Kaplan DR, Greene LA (1995) J Biol Chem 270: 3074-80.
26. Hakomori SH (1990) J Biol Chem 265: 18713-16.
27. Cheresh DA, Pierschbacher MD, Herzig MA, Mujoo K (1986) J Cell Biol 102: 688-96.
28. Rebbaa A, Bremer E, Portoukalian J (1995) Trends Glycosc Glycotechnol 7: 223-34.